Accendra Health, Inc.
NYSE:ACHMedical - Distribution
Healthcare
$0.71 +3.64%
+$0.12 today
- Market cap
- $54.22M
- Beta
- 1.63
- P/E (TTM)
- -0.2
- EPS (TTM)
- -$14.11
52W Low $1.84High $9.55
Volume 1.41M
Average 0.83M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$101.79M
FY 2025 · Annual
Investing Cash Flow
$144.42M
FY 2025 · Annual
Financing Cash Flow
$188.08M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 221.59M | 22.39M | (41.3M) | (362.69M) | (102.68M) |
| Depreciation & Amortization | 90.62M | 228.67M | 287.38M | 264.78M | 214.52M |
| Deferred Income Tax | (29.74M) | (26.36M) | (23.65M) | (26.12M) | (17.89M) |
| Stock-Based Compensation | 25.02M | 20.99M | 23.22M | 26.84M | 12.87M |
| Change in Working Capital | (261.4M) | 89.77M | 522.29M | (25.44M) | 65.21M |
| Accounts Receivables | (2.2M) | 1.1M | 166.58M | (94.55M) | 122.36M |
| Inventory | (263.44M) | 166.56M | 224.34M | (26.23M) | (6.85M) |
| Accounts Payables | 3.55M | 13.65M | 31M | 65.19M | 6.48M |
| Other Working Capital | 692K | (91.54M) | 100.37M | 30.15M | (56.78M) |
| Other Non-Cash Items | 78.09M | (10.45M) | (27.22M) | 284.12M | (273.83M) |
| Operating Cash Flow | 124.18M | 325.01M | 740.71M | 161.5M | (101.79M) |
| Capital Expenditures | (49.69M) | (166.58M) | (207.89M) | (228.16M) | (201.33M) |
| Acquisitions (Net) | (43.37M) | (1.68B) | 0 | 0 | 324.26M |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 39.43M | 46.71M | 53.62M | 94.33M | 11.12M |
| Investing Cash Flow | (53.63M) | (1.8B) | (137.25M) | (116.53M) | 144.42M |
| Debt Repayment | (95.35M) | 1.58B | (416.69M) | (244.2M) | 203.5M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (10.18M) |
| Dividends Paid | (731K) | 0 | 0 | 0 | 0 |
| Other Financing Activities | (33.4M) | (85.4M) | (637K) | (23.41M) | (5.24M) |
| Financing Cash Flow | (129.48M) | 1.5B | (417.33M) | (267.6M) | 188.08M |
| Effect of Forex Changes | (3.54M) | (3.49M) | 613K | (901K) | 1.9M |
| Net Change in Cash | (62.47M) | 14.15M | 186.74M | (223.54M) | 232.61M |
| Free Cash Flow | 74.49M | 158.42M | 532.82M | (66.67M) | (303.12M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$102.7M
+ D&A$214.5M
+ Stock-Based Comp$12.9M
- Deferred Tax-$17.9M
+ Working Capital$65.2M
- Other Non-Cash-$273.8M
= Operating Cash Flow-$101.8M
- Capex-$201.3M
= Free Cash Flow-$303.1M
Analysis
FY2025 free cash flow is -$303.1M. FCF conversion is 295.2% of net income. Operating cash flow was -$101.8M, with capex of -$201.3M. The largest bridge item is Other Non-Cash at -$273.8M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Sep 24, 2026 | |
| 8-K | Current report | Sep 17, 2026 | |
| 8-K | Current report | Aug 17, 2026 | |
| 10-Q | Quarterly report | Aug 10, 2026 | |
| 8-A12B | 8-A12B filing | Aug 10, 2026 |
Does ACH generate free cash flow?
Accendra Health, Inc. (ACH) generated -$303.12M of free cash flow in fiscal 2025.
How much operating cash flow does ACH produce?
Operating cash flow was -$101.79M, before capital expenditures of $201.32M.
Continue the stock analysis
Jump to another research area for this company.